![Online share trading app](https://bigul.co/stock-screener/assetData/img/bar-shape.png)
![Open free demat account](https://bigul.co/stock-screener/assetData/img/pointer.png)
Bullish Moving Averages
5
Bearish Moving Averages
2
Back Stocks profile
Open Price
848.90Prev. Close
854.2500Volume
378007.00Value
339053378.65Market Cap
14117.50
Price to Earnings
0.00
Price to Book Value
19.60
Dividend Yield
0.00
PE to Growth
0.00
Op Revenue TTM
0.00
Net Profit TTM
0.00
Cash From Operating Activity
498.26
Return on Equity %
-0.56
EMA & SMA
Bullish Moving Averages
5
Bearish Moving Averages
2
DELIVERY AND VOLUME
03 Sep, 2024
Week
Month
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
PIVOT
First Resistance
918.15
Second Resistance
939.35
Third Resistance
981.75
First Support
854.55
Second Support
812.15
Third Support
790.95
Relative Strength Index
57.8
Money Flow Index
31.54
MACD
MACD Signal
Average True Range
58.23
Average Directional Index
Rate of Change (21)
Rate of Change (125)
Commodity Channel Index
-35.7
Williams %R
-78.6
BETA
1 Month
3 Month
1 Year
3 Year
PRICE CHANGE ANALYSIS
1 Week
Low
High
821
898.3
1 Month
Low
High
725
1175.9
3 Months
Low
High
725
1175.9
6 Months
Low
High
725
1175.9
1 Year
Low
High
725
1175.9
Akums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Earnings / Analyst Conference Call held for limited reviewed un-audited financial results of Q1 FY25.Akums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of Earnings/Analysts Conference Call held for limited reviewed un-audited financial results of Q1 FY25.Akums Drugs and Pharmaceuticals back in black with 42 crore standalone net profit for June quarter
The company reported a revenue of 317 crore for the period under review. Revenues were near flat on a y-o-y basis at 316 croreAkums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper PublicationAkums Drugs and Pharmaceuticals Ltd - 544222 - Appointment Of Mr. Amrut Medhekar As Chief Executive Officer- CDMO Business
Appointment of Mr. Amrut Medhekar as Chief Executive Officer- CDMO BusinessAkums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor PresentationAkums Drugs and Pharmaceuticals Ltd - 544222 - Un-Audited Financial Results For The Quarter Ended 30.06.2024
Un-Audited Financial Results for the quarter ended 30.06.2024Akums Drugs and Pharmaceuticals Ltd - 544222 - Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board MeetingThe latest market price of Akums Drugs & Pharmaceuticals Ltd. on NSE was Rs. 896.95 as of today.
The opening share price of Akums Drugs & Pharmaceuticals Ltd. was Rs. 848.90 as of today.
The 52-week high share price of Akums Drugs & Pharmaceuticals Ltd. was Rs. 1175.90.
The 52 week low share price of Akums Drugs & Pharmaceuticals Ltd. was Rs. 725.00.
The PE ratio of Akums Drugs & Pharmaceuticals Ltd. is 0.00. Please refer to the Fundamentals section for further details.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.
Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.
Please refer to the News section for the latest news about Akums Drugs & Pharmaceuticals Ltd..